Pepex Biomedical, Inc. — Form D

Pepex Biomedical, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2012-04-27. The offering totals $3.0M, of which $202K was reported sold. Industry: Biotechnology.

Offering

Filed: 2012-04-27
Form: D
Accession: 0001547860-12-000002
Industry: Biotechnology
Exemptions: 06
Total offering: $3.0M
Amount sold: $202K
Remaining: $2.8M
Minimum investment: $202K
Investors: 1
Date of first sale: 2012-04-16
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-177341

Issuer

Name: Pepex Biomedical, Inc.
CIK: 0001547860
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2009
Address: 4041 FOREST PARK AVENUE, ST. LOUIS, MO, 63108
Phone: 314-633-5053

Officers, directors & promoters (10)

Name	Role	Location
STEVE COLLINS	Director	SALT LAKE CITY, UT
Joseph Driver	Director	St. Louis, MO
Nathan Long	Director	St. Louis, MO
Ira Potter	Director	St. Louis, MO
James Say	Director	St. Louis, MO
STEVE COLLINS	Executive Officer	SALT LAKE CITY, UT
Joseph Driver	Executive Officer	St. Louis, MO
James Say	Executive Officer	St. Louis, MO
STEVE COLLINS	Promoter	SALT LAKE CITY, UT
Joseph Driver	Promoter	St. Louis, MO

More